Róbert Halmosi

1.8k total citations
42 papers, 1.3k citations indexed

About

Róbert Halmosi is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Róbert Halmosi has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 12 papers in Pathology and Forensic Medicine and 11 papers in Molecular Biology. Recurrent topics in Róbert Halmosi's work include Cardiac Ischemia and Reperfusion (12 papers), PARP inhibition in cancer therapy (9 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Róbert Halmosi is often cited by papers focused on Cardiac Ischemia and Reperfusion (12 papers), PARP inhibition in cancer therapy (9 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Róbert Halmosi collaborates with scholars based in Hungary, United States and United Arab Emirates. Róbert Halmosi's co-authors include Kálmán Tóth, Balázs Sümegi, Eszter Szabados, László Deres, László Czopf, Klara Magyar, Anita Pálfi, Tamás Habon, Kálmán Hideg and Gergely Fehér and has published in prestigious journals such as PLoS ONE, Free Radical Biology and Medicine and Environmental Pollution.

In The Last Decade

Róbert Halmosi

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Róbert Halmosi Hungary 19 421 334 314 247 246 42 1.3k
Suresh Varma Penumathsa United States 18 591 1.4× 214 0.6× 351 1.1× 346 1.4× 70 0.3× 25 1.4k
Zhuoming Li China 19 710 1.7× 274 0.8× 231 0.7× 206 0.8× 112 0.5× 42 1.5k
Partha S. Ray United States 15 426 1.0× 75 0.2× 316 1.0× 213 0.9× 214 0.9× 30 1.3k
Miranda M. Sung Canada 24 956 2.3× 555 1.7× 214 0.7× 559 2.3× 226 0.9× 31 1.9k
István András Szijártó Germany 16 545 1.3× 260 0.8× 290 0.9× 490 2.0× 49 0.2× 29 1.5k
Paolo Nassi Italy 23 846 2.0× 223 0.7× 123 0.4× 359 1.5× 146 0.6× 76 1.7k
Zheng Yang China 28 814 1.9× 659 2.0× 79 0.3× 172 0.7× 144 0.6× 51 1.7k
Alexander Akhmedov Switzerland 25 686 1.6× 480 1.4× 125 0.4× 307 1.2× 108 0.4× 49 2.0k
Li‐Man Hung Taiwan 26 795 1.9× 387 1.2× 767 2.4× 727 2.9× 124 0.5× 66 2.5k

Countries citing papers authored by Róbert Halmosi

Since Specialization
Citations

This map shows the geographic impact of Róbert Halmosi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Róbert Halmosi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Róbert Halmosi more than expected).

Fields of papers citing papers by Róbert Halmosi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Róbert Halmosi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Róbert Halmosi. The network helps show where Róbert Halmosi may publish in the future.

Co-authorship network of co-authors of Róbert Halmosi

This figure shows the co-authorship network connecting the top 25 collaborators of Róbert Halmosi. A scholar is included among the top collaborators of Róbert Halmosi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Róbert Halmosi. Róbert Halmosi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sándor, Barbara, Anita Pálfi, László Deres, et al.. (2025). Prevalence and Cardiopulmonary Characteristics of Post-COVID Syndrome at a Hungarian Tertiary Referral Hospital. Journal of Clinical Medicine. 14(8). 2604–2604.
2.
Juhász, Kata, Katalin Fekete, Ferenc Gallyas, et al.. (2024). Cardiac effects of OPA1 protein promotion in a transgenic animal model. PLoS ONE. 19(11). e0310394–e0310394. 2 indexed citations
3.
Jackson, Scott, et al.. (2023). Substance Use-Associated Mortality among Heart Donors after the COVID-19 National Emergency Increased but Did Not Affect Peri-Transplant Outcomes. Journal of Cardiovascular Development and Disease. 10(5). 222–222. 2 indexed citations
4.
Halmosi, Róbert, et al.. (2023). Resveratrol and beyond: The Effect of Natural Polyphenols on the Cardiovascular System: A Narrative Review. Biomedicines. 11(11). 2888–2888. 26 indexed citations
5.
Deres, László, et al.. (2021). The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results. International Journal of Molecular Sciences. 22(18). 10152–10152. 77 indexed citations
6.
Deres, László, et al.. (2021). BGP‐15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats. Oxidative Medicine and Cellular Longevity. 2021(1). 1250858–1250858. 15 indexed citations
7.
Deres, László, Krisztián Erős, Barbara Sándor, et al.. (2020). Resveratrol Improves Heart Function by Moderating Inflammatory Processes in Patients with Systolic Heart Failure. Antioxidants. 9(11). 1108–1108. 40 indexed citations
8.
Kenyeres, P., et al.. (2020). Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol. Cardiovascular Therapeutics. 2020. 1–8. 24 indexed citations
9.
Tékus, Valéria, Ádám Horváth, Kata Csekő, et al.. (2020). Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats. Biomedicine & Pharmacotherapy. 134. 111105–111105. 9 indexed citations
10.
Deres, László, et al.. (2017). Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model. Oxidative Medicine and Cellular Longevity. 2017(1). 6819281–6819281. 97 indexed citations
11.
Erős, Krisztián, Klara Magyar, László Deres, et al.. (2017). Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats. PLoS ONE. 12(3). e0174401–e0174401. 7 indexed citations
12.
Halmosi, Róbert, et al.. (2016). PARP inhibition and postinfarction myocardial remodeling. International Journal of Cardiology. 217. S52–S59. 18 indexed citations
13.
Magyar, Klara, László Deres, Krisztián Erős, et al.. (2014). A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(7). 935–944. 22 indexed citations
14.
Szabó, Alíz, Klara Magyar, Eszter Szabados, et al.. (2011). Regulation of Kinase Cascade Activation and Heat Shock Protein Expression by Poly(ADP-ribose) Polymerase Inhibition in Doxorubicin-induced Heart Failure. Journal of Cardiovascular Pharmacology. 58(4). 380–391. 24 indexed citations
15.
Kiss, István, et al.. (2010). Enhancement of Organ Regeneration in Animal Models by a Stem Cell-Stimulating Plant Mixture. Journal of Medicinal Food. 13(3). 599–604. 1 indexed citations
16.
Pálfi, Anita, Ambrus Tóth, Katalin Hantó, et al.. (2005). The Role of Akt and Mitogen-Activated Protein Kinase Systems in the Protective Effect of Poly(ADP-Ribose) Polymerase Inhibition in Langendorff Perfused and in Isoproterenol-Damaged Rat Hearts. Journal of Pharmacology and Experimental Therapeutics. 315(1). 273–282. 43 indexed citations
17.
Tóth, Ambrus, Róbert Halmosi, Krisztina Kovács, et al.. (2003). Akt activation induced by an antioxidant compound during ischemia-reperfusion. Free Radical Biology and Medicine. 35(9). 1051–1063. 37 indexed citations
18.
Tóth, Ambrus, Zsolt Márton, László Czopf, et al.. (2001). QRS Score: A Composite Index of Exercise‐Induced Changes in the Q, R, and S Waves During Exercise Stress Testing in Patients with Ischemic Heart Disease. Annals of Noninvasive Electrocardiology. 6(4). 310–318. 10 indexed citations
19.
Márton, Zsolt, Róbert Halmosi, Beáta Horváth, et al.. (2001). Scavenger Effect of Experimental and Clinically Used Cardiovascular Drugs. Journal of Cardiovascular Pharmacology. 38(5). 745–753. 27 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suresh Varma Penumathsa Breakdown of academic impact, for papers by Zhuoming Li Breakdown of academic impact, for papers by Partha S. Ray Breakdown of academic impact, for papers by Miranda M. Sung Breakdown of academic impact, for papers by István András Szijártó Breakdown of academic impact, for papers by Paolo Nassi Breakdown of academic impact, for papers by Zheng Yang Breakdown of academic impact, for papers by Alexander Akhmedov Breakdown of academic impact, for papers by Li‐Man Hung
Rankless by CCL
2026